Search research articles
Contact Us
Filters
Showing results (51-60 of 92) with videos related to
Page
of 10
Sort By:
Human Toxicology
|
May 1, 1985
Orphenadrine serum levels in a poisoned patient
M Furlanut, D Bettio, I Bertin, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics
|
March 1, 1984
[Changes in plasma nonesterified fatty acids and blood glucose in the newborn infant in therapy with aminophylline]
V Zanardo, F Benini, P Pesenti, et al.
Pharmacological Research
|
February 8, 2000
Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy
M Baraldo, G Ferraccioli, F Pea, et al.
Pharmacological Research Communications
|
August 1, 1986
Plasma and tissue levels of flecainide in rats
D Piovan, R Padrini, M Furlanut, et al.
Pharmacological Research
|
February 1, 1992
Niaprazine vs chlordesmethyldiazepam in sleep disturbances in pediatric outpatients
G Montanari, P Schiaulini, A Covre, et al.
Pharmacological Research
|
June 1, 1996
Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis
M Furlanut, M Baraldo, F Galla, et al.
La Clinica Terapeutica
|
May 31, 1971
[Pharmacologico-clinical trials of the association of L-dopa and gamma-hydroxybutyric acid in therapy of Parkinson's disease]
M Ferrari, M Furlanut, L Battistin, et al.
Pharmacological Research
|
April 1, 1997
Levodopa and 3-O-methyldopa in cerebrospinal fluid after levodopa-carbidopa association
P Benetello, M Furlanut, M Fortunato, et al.
European Neurology
|
January 1, 1993
Plasma levels of levodopa and its main metabolites in parkinsonian patients after conventional and controlled-release levodopa-carbidopa associations
P Benetello, M Furlanut, G Zara, et al.
Pharmacological Research
|
December 1, 1995
Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods
G Wu, M Baraldo, F Pea, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 92) with videos related to
Sort By:
Page
of 10
Human Toxicology
|
May 1, 1985
Orphenadrine serum levels in a poisoned patient
M Furlanut, D Bettio, I Bertin, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics
|
March 1, 1984
[Changes in plasma nonesterified fatty acids and blood glucose in the newborn infant in therapy with aminophylline]
V Zanardo, F Benini, P Pesenti, et al.
Pharmacological Research
|
February 8, 2000
Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy
M Baraldo, G Ferraccioli, F Pea, et al.
Pharmacological Research Communications
|
August 1, 1986
Plasma and tissue levels of flecainide in rats
D Piovan, R Padrini, M Furlanut, et al.
Pharmacological Research
|
February 1, 1992
Niaprazine vs chlordesmethyldiazepam in sleep disturbances in pediatric outpatients
G Montanari, P Schiaulini, A Covre, et al.
Pharmacological Research
|
June 1, 1996
Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis
M Furlanut, M Baraldo, F Galla, et al.
La Clinica Terapeutica
|
May 31, 1971
[Pharmacologico-clinical trials of the association of L-dopa and gamma-hydroxybutyric acid in therapy of Parkinson's disease]
M Ferrari, M Furlanut, L Battistin, et al.
Pharmacological Research
|
April 1, 1997
Levodopa and 3-O-methyldopa in cerebrospinal fluid after levodopa-carbidopa association
P Benetello, M Furlanut, M Fortunato, et al.
European Neurology
|
January 1, 1993
Plasma levels of levodopa and its main metabolites in parkinsonian patients after conventional and controlled-release levodopa-carbidopa associations
P Benetello, M Furlanut, G Zara, et al.
Pharmacological Research
|
December 1, 1995
Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods
G Wu, M Baraldo, F Pea, et al.
Page
of 10